SEC Filing Details
Document Details
Form
Filing Date
Mar 22, 2024
Document Date
Mar 20, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
CRISPR Therapeutics
Issuer
CRISPR Therapeutics AG
Filer
KASINGER JAMES R.